Optura
-16%
est. 2Y upside i
Optura.AI transcends the traditional tech model, serving as a transformation enabler throughout the AI journey—from ideation to implementation and evolution. Our mission is to unlock AI’s potential in healthcare, driving better patient outcomes, cost optimization, and innovation.
Rank
#2673
Sector
Healthcare Technology / Enterprise Software
Est. Liquidity
~5Y
Data Quality
Data: LowDue to lack of revenue and valuation data, the equity upside is highly uncertain.
Last updated: July 3, 2026
If Optura achieves category leadership and IPO window opens, valuation could expand to 10x projected revenue; however revenue is unknown.
Moderate growth and multiple compression to comp range yields modest upside of 20% from entry valuation.
If exit value falls below $25M total funding, common stock is worth zero due to preference stack.
Preference Stack Risk
severeFunding Intensity
50%With $25M in total funding and an estimated valuation of $50M, preferred stock holds a 50% preference overhang, meaning common stock is at risk if exit below $25M.
Dilution Risk
highSeries A raised May 2026, likely 18-24 month runway; additional dilution expected in next round.
Secondary Liquidity
noneNo secondary trading reported.
Questions to Ask at the Interview
Strategic questions based on Optura's data — designed to show you've done your homework.
- 1
“How does Optura's ROAI framework create defensibility against Big Tech entrants?”
- 2
“What is the current revenue run rate and how does the company plan to scale sales in healthcare?”
- 3
“Given the early stage, what is the expected timeline to liquidity and how does the equity package compare to a more liquid opportunity?”
Community
Valuation Sentiment
Our model estimates -16% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.